Elekta (OTCMKTS:EKTAY – Get Free Report) issued its earnings results on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, Zacks reports. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.84%.
Elekta Stock Performance
Shares of Elekta stock opened at $6.63 on Thursday. The firm has a market cap of $2.44 billion, a PE ratio of -662.34 and a beta of 1.01. The firm’s 50-day simple moving average is $6.02 and its 200-day simple moving average is $5.98. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95. Elekta has a 1 year low of $4.35 and a 1 year high of $6.93.
About Elekta
Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.
The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.
Read More
- Five stocks we like better than Elekta
- Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Dick’s Sporting Goods Isn’t Done Winning Yet
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
Receive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.
